ArticleJournal of advanced research2022
Cooperating minimalist nanovaccine with PD-1 blockade for effective and feasible cancer immunotherapy.
Mingxia Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it